2m 2m 2m 2m 2m 2m 2m
UROGEN PHARMA (URGN)
NASDAQ
$38.59+$0.35 (+0.92%)
Price as of Aug 03, 2026 9:03 AM EDT- $1.8BMarket Cap
- 97.11%1-Year Change
- BiotechnologyIndustry
UROGEN PHARMA (URGN)
$38.59+$0.35 (+0.92%)
Earnings Score
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 57.30% | ||
12-Month Momentum | 99.06% | ||
3-Month Risk Adjusted Momentum | 238.53% | ||
12-Month Risk Adjusted Momentum | 154.32% |
True Yield
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -15.36% |
Financial Health Score
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |